Is Insulin Atherogenic?

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1988 Feb 1

PMID 3282955

Citations 17

Authors

R J Jarrett

Affiliations

Soon will be listed here.

Citing Articles

Enhancing insulin action: from chemical elements to thiazolidinediones.

Perfetti R, Chamie K J Endocrinol Invest. 2001; 24(4):274-87.

PMID: 11383915 DOI: 10.1007/BF03343858.

Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Wolffenbuttel B, van Haeften T Drugs. 1995; 50(2):263-88.

PMID: 8521759 DOI: 10.2165/00003495-199550020-00006.

Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I.

Zenobi P, Holzmann P, Glatz Y, Riesen W, FROESCH E Diabetologia. 1993; 36(5):465-9.

PMID: 8314453 DOI: 10.1007/BF00402285.

Absence of clinically overt atherosclerotic vascular disease and adverse changes in cardiovascular risk factors in 70 patients with insulinoma.

Leonetti F, Iozzo P, Giaccari A, Sbraccia P, Buongiorno A, Tamburrano G J Endocrinol Invest. 1993; 16(11):875-80.

PMID: 8144864 DOI: 10.1007/BF03348949.

Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.

Yarnell J, Sweetnam P, Marks V, Teale J, Bolton C Br Heart J. 1994; 71(3):293-6.

PMID: 8142201 PMC: 483669. DOI: 10.1136/hrt.71.3.293.

References

Cambien F, Chretien J, Ducimetiere P, Guize L, Richard J . Is the relationship between blood pressure and cardiovascular risk dependent on body mass index?. Am J Epidemiol. 1985; 122(3):434-42. DOI: 10.1093/oxfordjournals.aje.a114124. View

Welborn T, Breckenridge A, Rubinstein A, Dollery C, Fraser T . Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966; 1(7451):1336-7. DOI: 10.1016/s0140-6736(66)92132-5. View

Peters N, Hales C . PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION. Lancet. 1965; 1(7396):1144-5. DOI: 10.1016/s0140-6736(65)91962-8. View

Jarrett R, McCartney P, Keen H . The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 1982; 22(2):79-84. DOI: 10.1007/BF00254833. View

Janka H, Ziegler A, Standl E, Mehnert H . Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics. Diabete Metab. 1987; 13(3 Pt 2):359-64. View

Hockaday T . Serum insulin concentrations and anticipatory factors of cardiomyopathy in NIDDM. Diabete Metab. 1987; 13(3 Pt 2):354-8. View

Frohman L, Doeblin T, Emerling F . Diabetes in the Seneca Indians. Plasma insulin responses to oral carbohydrate. Diabetes. 1969; 18(1):38-43. DOI: 10.2337/diab.18.1.38. View

Welborn T, Wearne K . Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979; 2(2):154-60. DOI: 10.2337/diacare.2.2.154. View

Modan M, Halkin H, Fuchs Z, Lusky A, Chetrit A, Segal P . Hyperinsulinemia--a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance. Diabete Metab. 1987; 13(3 Pt 2):375-80. View

10.

Pyorala K, Uusitupa M, Laakso M, Siitonen O, Niskanen L, Ronnemaa T . Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus. Diabete Metab. 1987; 13(3 Pt 2):345-9. View

11.

NIKKILA E, Miettinen T, Vesenne M, PELKONEN R . Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide. Lancet. 1965; 2(7411):508-11. DOI: 10.1016/s0140-6736(65)91471-6. View

12.

Burke G, Webber L, Srinivasan S, Radhakrishnamurthy B, Freedman D, Berenson G . Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism. 1986; 35(5):441-6. DOI: 10.1016/0026-0495(86)90135-6. View

13.

Stout R . Insulin and atheroma--an update. Lancet. 1987; 1(8541):1077-9. DOI: 10.1016/s0140-6736(87)90495-8. View

14.

Cullen K, STENHOUSE N, Wearne K, Welborn T . Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study. J Chronic Dis. 1983; 36(5):371-7. DOI: 10.1016/0021-9681(83)90169-8. View

15.

Thomas B, Jarrett R, Keen H, Ruskin H . Relation of habitual diet to fasting plasma insulin concentration and the insulin response to oral glucose. Hum Nutr Clin Nutr. 1982; 36C(1):49-56. View

16.

Florey C, Uppal S, Lowy C . Relation between blood pressure, weight, and plasma sugar and serum insulin levels in schoolchildren aged 9-12 years in Westland, Holland. Br Med J. 1976; 1(6022):1368-71. PMC: 1640120. DOI: 10.1136/bmj.1.6022.1368. View

17.

Bjorntorp P . Adipose tissue distribution, plasma insulin, and cardiovascular disease. Diabete Metab. 1987; 13(3 Pt 2):381-5. View

18.

Young I, Stout R . Effects of insulin and glucose on the cells of the arterial wall: interaction of insulin with dibutyryl cyclic AMP and low density lipoprotein in arterial cells. Diabete Metab. 1987; 13(3 Pt 2):301-6. View

19.

Malherbe C, de Gasparo M, Berthet P, de Hertogh R, Hoet J . The Pattern of Plasma Insulin Response to Glucose in Patients with a Previous Myocardial Infarction-The Respective Effects of Age and Disease. Eur J Clin Invest. 2017; 1(4):265-270. DOI: 10.1111/eci.1971.1.4.265. View

20.

Ingelfinger J, BENNETT P, LIEBOW I, Miller M . Coronary heart disease in the Pima Indians. Electrocardiographic findings and postmortem evidence of myocardial infarction in a population with a high prevalence of diabetes mellitus. Diabetes. 1976; 25(7):561-5. DOI: 10.2337/diab.25.7.561. View